Back
Stryker Corp. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
31
SYK
Stryker Corp.
Last Price:
$354.18
Seasonality Move:
5.74%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$68.26
Seasonality Move:
10.04%
Sell
31
Stryker Corp. (SYK)
is a Sell
Is Stryker Corp. a Buy, Sell or Hold?
-
The current Stryker Corp. [SYK] share price is $354.22. The Score for SYK is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
SYK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $68.77. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SYK Stock Price Chart
What is Stryker Corp.'s stock price today?
-
The Stryker Corp. share price today is $354.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYK is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $68.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
SYK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 96.81 | Buy |
| Relative Strength Index (14 RSI): | 42.89 | Sell |
| Chaikin Money Flow: | -56199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (352.26 - 367.96) | Sell |
| Bollinger Bands (100): | (359.44 - 384.06) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.4 | Sell |
| Relative Strength Index (14 RSI): | 38.64 | Sell |
| Chaikin Money Flow: | -309210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.06 - 84.9) | Sell |
| Bollinger Bands (100): | (47.41 - 89.71) | Buy |
SYK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 354.11 | Buy |
| 20-day SMA: | 357.82 | Sell |
| 50-day SMA: | 364.18 | Sell |
| 200-day SMA: | 375.03 | Sell |
| 8-day EMA: | 293.57 | Buy |
| 20-day EMA: | 178.59 | Buy |
| 50-day EMA: | 86.58 | Buy |
| 200-day EMA: | 23.96 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.35 | Sell |
| 20-day SMA: | 74.69 | Sell |
| 50-day SMA: | 79.58 | Sell |
| 200-day SMA: | 53.14 | Buy |
| 8-day EMA: | 70.55 | Sell |
| 20-day EMA: | 74.01 | Sell |
| 50-day EMA: | 75.82 | Sell |
| 200-day EMA: | 57.21 | Buy |
Stryker Corp. Earnings Growth & SYK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $1.39 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Stryker Corp. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||